Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice

Peng Zhang, Caihong Xing, Steven D. Rhodes, Yongzheng He, Kai Deng, Zhaomin Li, Fuhong He, Caiying Zhu, Lihn Nguyen, Yuan Zhou, Shi Chen, Khalid S. Mohammad, Theresa A. Guise, Omar Abdel-Wahab, Mingjiang Xu, Qian Fei Wang, Feng-Chun Yang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

De novo ASXL1 mutations are found in patients with Bohring-Opitz syndrome, a disease with severe developmental defects and early childhood mortality. The underlying pathologic mechanisms remain largely unknown. Using Asxl1-targeted murine models, we found that Asxl1 global loss as well as conditional deletion in osteoblasts and their progenitors led to significant bone loss and a markedly decreased number of bone marrow stromal cells (BMSCs) compared with wild-type littermates. Asxl1 -/- BMSCs displayed impaired self-renewal and skewed differentiation, away from osteoblasts and favoring adipocytes. RNA-sequencing analysis revealed altered expression of genes involved in cell proliferation, skeletal development, and morphogenesis. Furthermore, gene set enrichment analysis showed decreased expression of stem cell self-renewal gene signature, suggesting a role of Asxl1 in regulating the stemness of BMSCs. Importantly, re-introduction of Asxl1 normalized NANOG and OCT4 expression and restored the self-renewal capacity of Asxl1 -/- BMSCs. Our study unveils a pivotal role of ASXL1 in the maintenance of BMSC functions and skeletal development. In this article, Yang, Wang, and colleagues show that loss of Asxl1 led to multiple skeletal developmental defects, closely reminiscent of Bohring-Opitz syndrome. They identified that the skeletal defects were associated with an impaired self-renewal and skewed lineage commitment of bone marrow stromal cells (BMSCs). These findings indicate a pivotal role of ASXL1 in the maintenance of BMSC functions and skeletal development.

Original languageEnglish (US)
JournalStem Cell Reports
DOIs
StateAccepted/In press - Jan 26 2016

Fingerprint

Mesenchymal Stromal Cells
Bone
Genes
Osteoblasts
Defects
Maintenance
RNA Sequence Analysis
Cell Self Renewal
Bohring syndrome
Morphogenesis
Adipocytes
Cell proliferation
Stem cells
Cell Proliferation
Gene Expression
Bone and Bones
RNA
Mutation
Mortality

Keywords

  • ASXL1 mutation
  • Bohring-Opitz syndrome
  • Bone marrow stromal cell
  • Self-renewal and differentiation
  • Skeletal development

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Developmental Biology
  • Genetics

Cite this

Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice. / Zhang, Peng; Xing, Caihong; Rhodes, Steven D.; He, Yongzheng; Deng, Kai; Li, Zhaomin; He, Fuhong; Zhu, Caiying; Nguyen, Lihn; Zhou, Yuan; Chen, Shi; Mohammad, Khalid S.; Guise, Theresa A.; Abdel-Wahab, Omar; Xu, Mingjiang; Wang, Qian Fei; Yang, Feng-Chun.

In: Stem Cell Reports, 26.01.2016.

Research output: Contribution to journalArticle

Zhang, P, Xing, C, Rhodes, SD, He, Y, Deng, K, Li, Z, He, F, Zhu, C, Nguyen, L, Zhou, Y, Chen, S, Mohammad, KS, Guise, TA, Abdel-Wahab, O, Xu, M, Wang, QF & Yang, F-C 2016, 'Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice', Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2016.04.013
Zhang, Peng ; Xing, Caihong ; Rhodes, Steven D. ; He, Yongzheng ; Deng, Kai ; Li, Zhaomin ; He, Fuhong ; Zhu, Caiying ; Nguyen, Lihn ; Zhou, Yuan ; Chen, Shi ; Mohammad, Khalid S. ; Guise, Theresa A. ; Abdel-Wahab, Omar ; Xu, Mingjiang ; Wang, Qian Fei ; Yang, Feng-Chun. / Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice. In: Stem Cell Reports. 2016.
@article{65a7f462d8324081bea0d53943475928,
title = "Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice",
abstract = "De novo ASXL1 mutations are found in patients with Bohring-Opitz syndrome, a disease with severe developmental defects and early childhood mortality. The underlying pathologic mechanisms remain largely unknown. Using Asxl1-targeted murine models, we found that Asxl1 global loss as well as conditional deletion in osteoblasts and their progenitors led to significant bone loss and a markedly decreased number of bone marrow stromal cells (BMSCs) compared with wild-type littermates. Asxl1 -/- BMSCs displayed impaired self-renewal and skewed differentiation, away from osteoblasts and favoring adipocytes. RNA-sequencing analysis revealed altered expression of genes involved in cell proliferation, skeletal development, and morphogenesis. Furthermore, gene set enrichment analysis showed decreased expression of stem cell self-renewal gene signature, suggesting a role of Asxl1 in regulating the stemness of BMSCs. Importantly, re-introduction of Asxl1 normalized NANOG and OCT4 expression and restored the self-renewal capacity of Asxl1 -/- BMSCs. Our study unveils a pivotal role of ASXL1 in the maintenance of BMSC functions and skeletal development. In this article, Yang, Wang, and colleagues show that loss of Asxl1 led to multiple skeletal developmental defects, closely reminiscent of Bohring-Opitz syndrome. They identified that the skeletal defects were associated with an impaired self-renewal and skewed lineage commitment of bone marrow stromal cells (BMSCs). These findings indicate a pivotal role of ASXL1 in the maintenance of BMSC functions and skeletal development.",
keywords = "ASXL1 mutation, Bohring-Opitz syndrome, Bone marrow stromal cell, Self-renewal and differentiation, Skeletal development",
author = "Peng Zhang and Caihong Xing and Rhodes, {Steven D.} and Yongzheng He and Kai Deng and Zhaomin Li and Fuhong He and Caiying Zhu and Lihn Nguyen and Yuan Zhou and Shi Chen and Mohammad, {Khalid S.} and Guise, {Theresa A.} and Omar Abdel-Wahab and Mingjiang Xu and Wang, {Qian Fei} and Feng-Chun Yang",
year = "2016",
month = "1",
day = "26",
doi = "10.1016/j.stemcr.2016.04.013",
language = "English (US)",
journal = "Stem Cell Reports",
issn = "2213-6711",
publisher = "Cell Press",

}

TY - JOUR

T1 - Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice

AU - Zhang, Peng

AU - Xing, Caihong

AU - Rhodes, Steven D.

AU - He, Yongzheng

AU - Deng, Kai

AU - Li, Zhaomin

AU - He, Fuhong

AU - Zhu, Caiying

AU - Nguyen, Lihn

AU - Zhou, Yuan

AU - Chen, Shi

AU - Mohammad, Khalid S.

AU - Guise, Theresa A.

AU - Abdel-Wahab, Omar

AU - Xu, Mingjiang

AU - Wang, Qian Fei

AU - Yang, Feng-Chun

PY - 2016/1/26

Y1 - 2016/1/26

N2 - De novo ASXL1 mutations are found in patients with Bohring-Opitz syndrome, a disease with severe developmental defects and early childhood mortality. The underlying pathologic mechanisms remain largely unknown. Using Asxl1-targeted murine models, we found that Asxl1 global loss as well as conditional deletion in osteoblasts and their progenitors led to significant bone loss and a markedly decreased number of bone marrow stromal cells (BMSCs) compared with wild-type littermates. Asxl1 -/- BMSCs displayed impaired self-renewal and skewed differentiation, away from osteoblasts and favoring adipocytes. RNA-sequencing analysis revealed altered expression of genes involved in cell proliferation, skeletal development, and morphogenesis. Furthermore, gene set enrichment analysis showed decreased expression of stem cell self-renewal gene signature, suggesting a role of Asxl1 in regulating the stemness of BMSCs. Importantly, re-introduction of Asxl1 normalized NANOG and OCT4 expression and restored the self-renewal capacity of Asxl1 -/- BMSCs. Our study unveils a pivotal role of ASXL1 in the maintenance of BMSC functions and skeletal development. In this article, Yang, Wang, and colleagues show that loss of Asxl1 led to multiple skeletal developmental defects, closely reminiscent of Bohring-Opitz syndrome. They identified that the skeletal defects were associated with an impaired self-renewal and skewed lineage commitment of bone marrow stromal cells (BMSCs). These findings indicate a pivotal role of ASXL1 in the maintenance of BMSC functions and skeletal development.

AB - De novo ASXL1 mutations are found in patients with Bohring-Opitz syndrome, a disease with severe developmental defects and early childhood mortality. The underlying pathologic mechanisms remain largely unknown. Using Asxl1-targeted murine models, we found that Asxl1 global loss as well as conditional deletion in osteoblasts and their progenitors led to significant bone loss and a markedly decreased number of bone marrow stromal cells (BMSCs) compared with wild-type littermates. Asxl1 -/- BMSCs displayed impaired self-renewal and skewed differentiation, away from osteoblasts and favoring adipocytes. RNA-sequencing analysis revealed altered expression of genes involved in cell proliferation, skeletal development, and morphogenesis. Furthermore, gene set enrichment analysis showed decreased expression of stem cell self-renewal gene signature, suggesting a role of Asxl1 in regulating the stemness of BMSCs. Importantly, re-introduction of Asxl1 normalized NANOG and OCT4 expression and restored the self-renewal capacity of Asxl1 -/- BMSCs. Our study unveils a pivotal role of ASXL1 in the maintenance of BMSC functions and skeletal development. In this article, Yang, Wang, and colleagues show that loss of Asxl1 led to multiple skeletal developmental defects, closely reminiscent of Bohring-Opitz syndrome. They identified that the skeletal defects were associated with an impaired self-renewal and skewed lineage commitment of bone marrow stromal cells (BMSCs). These findings indicate a pivotal role of ASXL1 in the maintenance of BMSC functions and skeletal development.

KW - ASXL1 mutation

KW - Bohring-Opitz syndrome

KW - Bone marrow stromal cell

KW - Self-renewal and differentiation

KW - Skeletal development

UR - http://www.scopus.com/inward/record.url?scp=84969754396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969754396&partnerID=8YFLogxK

U2 - 10.1016/j.stemcr.2016.04.013

DO - 10.1016/j.stemcr.2016.04.013

M3 - Article

JO - Stem Cell Reports

JF - Stem Cell Reports

SN - 2213-6711

ER -